Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Promising laboratory findings and phase I results reported for Leukine

Feb. 6, 1998

Glaxo Wellcome's new NRTI highlighted at AIDS conference

Feb. 6, 1998

FddA demonstrates anti-HIV activity at well-tolerated doses in phase I trial

Feb. 5, 1998

Pharmacokinetics and drug interactions for Fortovase

Feb. 5, 1998

PNU-140690: clinical pharmacokinetics and safety after single and multiple doses

Feb. 5, 1998

Multiple-dose phase I trial of FP-21399 in HIV discussed at AIDS conference

Feb. 5, 1998

Early clinical results support potential of ABT-378/ritonavir combination

Feb. 5, 1998

Warner-Lambert presents SAR for potent, nonpeptide HIV protease inhibitor at AIDS conference

Feb. 5, 1998

Calanolide A well tolerated in phase I trials

Feb. 5, 1998

Continued HIV suppression requires triple drug maintenance therapy

Feb. 4, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...